Sacheerome Ltd Q4 FY26 Results & Concall Highlights: Revenue, Margins & Order Book
Published 15 Jul 2026 | Chemicals & Petrochemicals | Market Cap: ₹1.0K Cr
Sacheerome is experiencing strong demand growth in the FMCG industry, with increasing product launches and customer acceptance both domestically and globally. Operating margins (EBIT) for FY26 were around 25%; management aims to sustain this level.
From Sacheerome Ltd's Q4 FY26 earnings-call transcript · updated 3 Sept 2026.
Price
₹420
Market Cap
₹1.0K Cr
P/E Ratio
35.8
Revenue Rank
Margin Rank
How does Sacheerome Ltd rank in Chemicals & Petrochemicals?
Compare Sacheerome Ltd against every Chemicals & Petrochemicals company this quarter on revenue, margins and earnings-call signals.
📊 Revenue & Sales Performance
Rank 2- →Sacheerome is experiencing strong demand growth in the FMCG industry, with increasing product launches and customer acceptance both domestically and globally.
- →The company is expanding manufacturing capacity significantly (4x increase with a new facility at YEIDA, expected commercial operations from August 2026).
- →Revenue guidance is to double from ~INR152 crore in FY26 to ~INR300 crore by FY29, reflecting a conservative approach.
- →Strong pipeline of development projects and product approvals across fragrances and flavors supporting future revenue growth.
- →Export volumes and value are increasing steadily, although domestic market remains the primary focus.
- →Capacity utilization and revenue ramp-up expected to be gradual over next few years, matching market demand and customer additions.
- →Innovation and proprietary technology embedded in products expected to enhance product performance and competitiveness, supporting growth.
- →Management committed to maintaining operating margins (~25%) while scaling business sustainably.
See what Sacheerome Ltd said on profitability & margins — free account, 30 seconds.
🏗️ Capital Expenditure Plans
Yes- →Sacheerome Limited is undertaking a significant capital investment with the construction of a new manufacturing facility in the Yamuna Expressway Industrial Development Area (YEIDA).
- →Total planned capex for the YEIDA facility is approximately INR 184 crores.
- →As of March 31, 2026, INR 76.59 crores has been invested, with INR 28.79 crores from IPO proceeds and INR 47.80 crores from internal accruals.
- →The new facility will multiply the production capacity by 4 times, addressing current capacity constraints as existing operations are running at about 124% utilization.
- →Commercial operations for this facility are expected to commence from August 2026.
- →The YEIDA facility is a strategic investment aimed at enhancing automation, manufacturing efficiency, product consistency, export capabilities, and scalability over the next decade.
- →Around INR 60 crores of debt is planned to be taken as needed to fund part of the capex.
See what Sacheerome Ltd said on fundraising & capital structure — free account, 30 seconds.
📋 Order Book & Pipeline
No information- →The transcript does not explicitly mention the exact current or expected order book or pending orders for Sacheerome Limited.
- →However, it is indicated that the company is operating at above 120% capacity utilization, reflecting strong demand.
- →There is a significant pipeline of development projects, product approvals, and commercial launches, especially in fragrance and flavor segments.
- →Management emphasized numerous pending customer demand opportunities which could not be fulfilled earlier due to capacity constraints.
- →The new facility expansion (with capex of INR184 crores) aims to cater to this growing demand and will multiply production capacity by 4x.
- →The company is optimistic about ramping up production gradually after the new plant commissioning expected around August 2026.
- →The management cited a growing pipeline and increasing demand from both domestic and global customers, implying a substantial order backlog feeding future growth.
Key Metrics
Revenue
Margin
Capex
Fundraise
Order Book
Continue your research
What Sacheerome Ltd's management said in earlier quarters
Others in Chemicals & Petrochemicals this season
- NOCIL (Q4 FY26)
The Rs.130 crores capex includes some intermediates and is largely for captive consumption, with part allocated to finished goods. Key concall takeaways from…
- Indo Borax & Chemicals Ltd (Q4 FY26)
175 crores revenue in the previous financial year and Rs. Key concall takeaways from Indo Borax & Chemicals Ltd's Q4 FY26 earnings call — and how it ranks…
- Rossari Biotech (Q4 FY26)
50-70 crore planned for FY27 focused on pharma and aroma chemical facilities to support value-added product segments. Key concall takeaways from Rossari…
- Pidilite Inds. (Q4 FY26)
Underlying volume growth (UVG) averaged over 9% per quarter last year, with a ~200 bps increase in FY '25; the company plans to continue lifting UVG…
Frequently Asked Questions
What were Sacheerome Ltd Q4 FY26 results?
Sacheerome is experiencing strong demand growth in the FMCG industry, with increasing product launches and customer acceptance both domestically and globally. Operating margins (EBIT) for FY26 were around 25%; management aims to sustain this level.
What is Sacheerome Ltd share price analysis?
Sacheerome Ltd currently shows a moderate growth signal based on ranking data. The stock trades at a P/E of 35.8 with a market cap of ₹1,019 Cr. Investors should review the full earnings analysis for detailed insights.
Is Sacheerome Ltd planning capital expenditure?
Sacheerome Limited is undertaking a significant capital investment with the construction of a new manufacturing facility in the Yamuna Expressway Industrial Development Area (YEIDA).
Keep Sacheerome Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.